Sign in

Shreyas Joshi, MD

@ssjoshi.bsky.social
139 followers 61 following 4 posts

Assistant Professor in Urologic Oncology, Emory University, Winship Cancer Institute

PostsRepliesMedia
Reposted by Shreyas Joshi, MD
Vikram M. Narayan, MD @drnarayan.com · 04/11/2025
Join us for our SUO Fellowship Virtual Open House on January 13, 2026, 7-8 PM EST @ssjoshi.bsky.social @emoryuroonc.bsky.social . Register here: zoom.us/meeting/regi...
031
Reposted by Shreyas Joshi, MD
Vikram M. Narayan, MD @drnarayan.com · 23/05/2025
My thanks to my #EmoryUrology family and the teams at #Apple and @hey.epic.com for helping us tell the @emoryhealthcareatl.bsky.social story of how clinician well-being is being prioritized through the use of great technology www.apple.com/healthcare/s...
apple.com
Healthcare - Success Stories
Read the success stories of how health organizations around the world use Apple technology to reduce clinician burnout and deliver personalized care.
292
Reposted by Shreyas Joshi, MD
Emory Urologic Oncology @emoryuroonc.bsky.social · 30/04/2025
Congratulations to our very own @tgoodstein.bsky.social for being awarded the 2025 Society of Urologic Oncology #CGOncology #NMIBC Fellowship Grant at #AUA2025 @ssjoshi.bsky.social @drnarayan.com
022
Reposted by Shreyas Joshi, MD
Vikram M. Narayan, MD @drnarayan.com · 01/02/2025
Thanks again to Tommy Korn and everyone at Sharp Healthcare for hosting a fantastic Spatial Computing Health Care Summit - awesome to see all the amazing things people have been doing with Apple #VisionPro & to share some of what we’ve been able to do with our partners at #KarlStorz #SharpSpatial
181
Reposted by Shreyas Joshi, MD
Valentina Grajales MD MS @valentinagrajales.bsky.social · 25/01/2025
“Grateful to be at #SWIU surrounded by incredible women—friends, colleagues, and mentees. Inspired by the exchange of ideas and learning about topics that truly empower us to lead fulfilled and successful lives. Here’s to growth, community, and innovation! 🩷 #WomenInUrology” @emoryuroonc.bsky.social
Emory Urology
094
Reposted by Shreyas Joshi, MD
Emory Urologic Oncology @emoryuroonc.bsky.social · 12/01/2025
Interested in learning about Emory’s #SUO fellowship? 📆 Join us for a virtual open house on Thursday, Jan 16th from 7-8 PM EST DM or email us if you’re interested -we’ll send you a link! @ssjoshi.bsky.social @valentinagrajales.bsky.social @tgoodstein.bsky.social @winshipatemory.bsky.social
053
Reposted by Shreyas Joshi, MD
Vikram M. Narayan, MD @drnarayan.com · 06/12/2024
Proud of our first @emoryuroonc.bsky.social SUO fellow #TaylorGoodstein making a splash in RCC research at the #SUO24 Winter Meeting @ssjoshi.bsky.social @jackiebrownmd.bsky.social
073
Shreyas Joshi, MD @ssjoshi.bsky.social · 05/12/2024
Packed house at SUO2024 for NMIBC discussion. Our thought leader @drnarayan.com from @emoryuroonc.bsky.social @winshipatemory.bsky.social Ongoing challenge: how do we manage high risk NMIBC? Especially those with variants? @valentinagrajales.bsky.social
093
Reposted by Shreyas Joshi, MD
Vikram M. Narayan, MD @drnarayan.com · 27/11/2024
Interesting study…only 56% OS at 5 years strikes me as lower than I would expect; by comparison an 80% 5 year OS was observed in the ph3 nado trial for BCG unresponsive pts (76% in CIS only patients, 86% in papillary dz). Worth calling out the 53% grade 3 AE rate as well… @emoryuroonc.bsky.social
031
Shreyas Joshi, MD @ssjoshi.bsky.social · 27/11/2024
Urology residents of @bsky.app , let us know if you will be in Dallas for SUO 2024 and would like to chat about the @emoryuroonc.bsky.social SUO Fellowship! @drnarayan.com @valentinagrajales.bsky.social
063
Shreyas Joshi, MD @ssjoshi.bsky.social · 25/11/2024
@emoryuroonc.bsky.social welcome to Bluesky!
033
Reposted by Shreyas Joshi, MD
Elizabeth Plimack MD @erplimackmd.bsky.social · 22/11/2024
Join the conversation on all things #bladdercancer #kidneycancer #prostatecancer and help grow the GU Oncology Starter Pack go.bsky.app/6NdMXmY
7219
Reposted by Shreyas Joshi, MD
BJUI & BJUI Compass @bjuijournal.bsky.social · 19/11/2024
The non-coding RNA based classifier identifies urothelial carcinomas harboring less aggressive tumor biology associated with favorable outcomes after radical cystectomy doi.org/10.1111/bju....
doi.org
A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy
Objective To further evaluate a genomic classifier (GC) in a cohort of patients undergoing radical cystectomy (RC), as long non-coding RNA (lncRNA)-based genomic profiling has suggested utility in i...
083